These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

635 related articles for article (PubMed ID: 20440089)

  • 21. Insulin and androgen relationships with abdominal body fat distribution in women with and without hyperandrogenism.
    Pasquali R; Casimirri F; Cantobelli S; Labate AM; Venturoli S; Paradisi R; Zannarini L
    Horm Res; 1993; 39(5-6):179-87. PubMed ID: 8314200
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adipocyte and steroidogenic cell cross-talk in polycystic ovary syndrome.
    de Medeiros SF; Rodgers RJ; Norman RJ
    Hum Reprod Update; 2021 Jun; 27(4):771-796. PubMed ID: 33764457
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of obesity and polycystic ovary syndrome in adolescents.
    Vilmann LS; Thisted E; Baker JL; Holm JC
    Horm Res Paediatr; 2012; 78(5-6):269-78. PubMed ID: 23208318
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Associations of menstrual cycle irregularities with age, obesity and phenotype in patients with polycystic ovary syndrome.
    Panidis D; Tziomalos K; Papadakis E; Chatzis P; Kandaraki EA; Tsourdi EA; Macut D; Bjekic-Macut J; Marthopoulos A; Katsikis I
    Hormones (Athens); 2015; 14(3):431-7. PubMed ID: 26188231
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A systematic review of GLP-1 on anthropometrics, metabolic and endocrine parameters in patients with PCOS.
    Bader S; Bhatti R; Mussa B; Abusanana S
    Womens Health (Lond); 2024; 20():17455057241234530. PubMed ID: 38444070
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Central arterial stiffness and diastolic dysfunction are associated with insulin resistance and abdominal obesity in young women but polycystic ovary syndrome does not confer additional risk.
    Rees E; Coulson R; Dunstan F; Evans WD; Blundell HL; Luzio SD; Dunseath G; Halcox JP; Fraser AG; Rees DA
    Hum Reprod; 2014 Sep; 29(9):2041-9. PubMed ID: 25035436
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and biochemical presentations of polycystic ovary syndrome among obese and nonobese women.
    Liou TH; Yang JH; Hsieh CH; Lee CY; Hsu CS; Hsu MI
    Fertil Steril; 2009 Dec; 92(6):1960-5. PubMed ID: 18980763
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Androgen levels and metabolic parameters are associated with a genetic variant of F13A1 in women with polycystic ovary syndrome.
    Schweighofer N; Lerchbaum E; Trummer O; Schwetz V; Pilz S; Pieber TR; Obermayer-Pietsch B
    Gene; 2012 Aug; 504(1):133-9. PubMed ID: 22565190
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polycystic Ovary Syndrome among Obese Adolescents.
    Ybarra M; Franco RR; Cominato L; Sampaio RB; Sucena da Rocha SM; Damiani D
    Gynecol Endocrinol; 2018 Jan; 34(1):45-48. PubMed ID: 28758509
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adipocyte fatty acid-binding protein is associated with markers of obesity, but is an unlikely link between obesity, insulin resistance, and hyperandrogenism in polycystic ovary syndrome women.
    Möhlig M; Weickert MO; Ghadamgadai E; Machlitt A; Pfüller B; Arafat AM; Pfeiffer AF; Schöfl C
    Eur J Endocrinol; 2007 Aug; 157(2):195-200. PubMed ID: 17656598
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polycystic ovary syndrome: reviewing diagnosis and management of metabolic disturbances.
    Spritzer PM
    Arq Bras Endocrinol Metabol; 2014 Mar; 58(2):182-7. PubMed ID: 24830595
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pregnancy complications in women with polycystic ovary syndrome.
    Palomba S; de Wilde MA; Falbo A; Koster MP; La Sala GB; Fauser BC
    Hum Reprod Update; 2015; 21(5):575-92. PubMed ID: 26117684
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Associations of childhood adiposity with menstrual irregularity and polycystic ovary syndrome in adulthood: the Childhood Determinants of Adult Health Study and the Bogalusa Heart Study.
    He Y; Tian J; Blizzard L; Oddy WH; Dwyer T; Bazzano LA; Hickey M; Harville EW; Venn AJ
    Hum Reprod; 2020 May; 35(5):1185-1198. PubMed ID: 32344436
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of socio-demographic and clinical characteristics of PCOS patients attending a tertiary care institute in Colombo.
    Ranathunga I; Athukorala TG; Sumanatilleke MR; Somasundaram NP
    BMC Endocr Disord; 2022 Nov; 22(1):289. PubMed ID: 36411444
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lifestyle intervention up-regulates gene and protein levels of molecules involved in insulin signaling in the endometrium of overweight/obese women with polycystic ovary syndrome.
    Ujvari D; Hulchiy M; Calaby A; Nybacka Å; Byström B; Hirschberg AL
    Hum Reprod; 2014 Jul; 29(7):1526-35. PubMed ID: 24842895
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Visceral adiposity index as a predictor of clinical severity and therapeutic outcome of PCOS.
    Zheng SH; Li XL
    Gynecol Endocrinol; 2016; 32(3):177-83. PubMed ID: 26502288
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Digit ratios do not serve as anatomical evidence of prenatal androgen exposure in clinical phenotypes of polycystic ovary syndrome.
    Lujan ME; Bloski TG; Chizen DR; Lehotay DC; Pierson RA
    Hum Reprod; 2010 Jan; 25(1):204-11. PubMed ID: 19855107
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Influence of weight and distribution of adipose tissue in functional hyperandrogenism].
    Pasquali R; Vicennati V; Gambineri A
    Contracept Fertil Sex; 1998 May; 26(5):372-5. PubMed ID: 9648381
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ethinylestradiol-drospirenone, flutamide-metformin, or both for adolescents and women with hyperinsulinemic hyperandrogenism: opposite effects on adipocytokines and body adiposity.
    Ibáñez L; de Zegher F
    J Clin Endocrinol Metab; 2004 Apr; 89(4):1592-7. PubMed ID: 15070917
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bariatric Surgery Improves Hyperandrogenism, Menstrual Irregularities, and Metabolic Dysfunction Among Women with Polycystic Ovary Syndrome (PCOS).
    Christ JP; Falcone T
    Obes Surg; 2018 Aug; 28(8):2171-2177. PubMed ID: 29500679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.